Portal venous invasion: The single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 11, 2011, Pages 1646-1651

  Choi, Kang Kook ^a   Kim, Sung Hoon ^a   Choi, Sae Byeol ^b   Lim, Jin Hong ^a   Choi, Gi Hong ^a   Choi, Jin Sub ^a   Kim, Kyung Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Recurrence; Risk factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OPERATION DURATION; PORTAL VEIN; PRIORITY JOURNAL; RISK FACTOR; TUMOR DIFFERENTIATION;

EID: 80054886995     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06780.x     Document Type: Article

References (26)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann. Surg. 1999; 229: 790-9.
3. Nagasue N, Uchida M, Makino Y etal. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-94.
4. Shimada M, Takenaka K, Gion T etal. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-6.
5. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89: 500-7.
6. Lu X, Zhao H, Yang H etal. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J. Surg. Oncol. 2009; 100: 488-93.
7. Regimbeau JM, Abdalla EK, Vauthey JN etal. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J. Surg. Oncol. 2004; 85: 36-41.
8. Imamura H, Matsuyama Y, Tanaka E etal. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J. Hepatol. 2003; 38: 200-7.
9. Kim H, Park M, Park YN etal. Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection. Yonsei Med. J. 2009; 50: 789-95.
10. Ou D, Yang L, Huang G, Tao Y, Ding X, Chang Z. Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV. World J. Gastroenterol. 2005; 11: 2061-6.
11. Shah SA, Greig PD, Gallinger S etal. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J. Am. Coll. Surg. 2006; 202: 275-83.
12. Zhou Y, Yang J, Li B etal. Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat. Dis. Int. 2010; 9: 33-7.
13. Kim B, Kim Y, Wang H, Kim M. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J. Gastroenterol. 2006; 12: 99-104.
14. Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology 1989; 9: 457-60.
15. Toyosaka A, Okamoto E, Mitsunobu M, Oriyama T, Nakao N, Miura K. Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma; the role of efferent vessels. HPB Surg. 1996; 10: 97-103.
16. Yamamoto J, Kosuge T, Takayama T etal. Recurrence of hepatocellular carcinoma after surgery. Br. J. Surg. 1996; 83: 1219-22.
17. Yamanaka J, Yamanaka N, Nakasho K etal. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J. Gastroenterol. Hepatol. 2000; 15: 1192-8.
18. Kim BK, Han KH, Park YN etal. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J. Surg. Oncol. 2008; 97: 246-52.
19. Sherman M. Alphafetoprotein: an obituary. J. Hepatol. 2001; 34: 603-5.
20. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch. Surg. 1999; 134: 1124-30.
21. Zhang XF, Meng B, Qi X etal. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival. Eur. J. Surg. Oncol. 2009; 35: 622-8.
22. Eguchi S, Takatsuki M, Hidaka M etal. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J. Surg. 2010; 34: 1034-8.
23. Esnaola NF, Lauwers GY, Mirza NQ etal. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J. Gastrointest. Surg. 2002; 6: 224-32.
24. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J. Surg. Oncol. 2010; 102: 462-8.
25. Kim H, Park M, Choi JY etal. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur. Radiol. 2009; 19: 1744-51.
26. Kim DH, Paik YH, Ahn SH etal. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 2007; 72 (Suppl. 1): 52-7.